Lenvatinib and Pembrolizumab Simultaneous Combination Study

NCT03609359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Advanced Gastric Cancer

Interventions

DRUG: Lenvatinib
DRUG: Pembrolizumab

Sponsor

National Cancer Center Hospital East

Collaborators

[object Object]
[object Object]